The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[3-(2-Bromo-ethoxy)-4-chloro-1-oxo-1H-isochromen-7-ylcarbamoyl]-butyric acid methyl ester ID: ALA357115
PubChem CID: 10253017
Max Phase: Preclinical
Molecular Formula: C17H17BrClNO6
Molecular Weight: 446.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)CCCC(=O)Nc1ccc2c(Cl)c(OCCBr)oc(=O)c2c1
Standard InChI: InChI=1S/C17H17BrClNO6/c1-24-14(22)4-2-3-13(21)20-10-5-6-11-12(9-10)16(23)26-17(15(11)19)25-8-7-18/h5-6,9H,2-4,7-8H2,1H3,(H,20,21)
Standard InChI Key: CLIISUBHEBQZTF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
7.4792 -6.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4792 -5.3375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7167 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7167 -6.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -6.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -5.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2000 -6.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9042 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6750 -4.8917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7167 -4.0042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1500 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4375 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7167 -7.5417 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.9042 -6.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1500 -6.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2500 -6.6625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -6.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9208 -4.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5417 -6.2167 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6125 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3792 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7792 -6.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0125 -6.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9208 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 4 1 0
6 5 2 0
7 5 1 0
8 10 1 0
9 6 1 0
10 13 1 0
11 3 2 0
12 22 1 0
13 18 1 0
14 4 1 0
15 8 2 0
16 12 2 0
17 1 1 0
18 7 2 0
19 12 1 0
20 24 1 0
21 8 1 0
22 23 1 0
23 21 1 0
24 25 1 0
25 17 1 0
26 19 1 0
3 6 1 0
13 9 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 446.68Molecular Weight (Monoisotopic): 444.9928AlogP: 3.50#Rotatable Bonds: 8Polar Surface Area: 94.84Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.50CX Basic pKa: ┄CX LogP: 2.96CX LogD: 2.96Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -0.57
References 1. Kerrigan JE, Oleksyszyn J, Kam CM, Selzler J, Powers JC.. (1995) Mechanism-based isocoumarin inhibitors for human leukocyte elastase. Effect of the 7-amino substituent and 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency., 38 (3): [PMID:7853347 ] [10.1021/jm00003a017 ]